WebDisclosure WebDisclosure
Basculer en Français
10051 Companies
205096 Keywords
135327 Articles
108732 Press releases
Headlines Articles Press releases Moderna, Inc. Remove
  1. Home
  2. Companies
  3. Moderna, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/30/2023 at 13:15, 3 years 1 month ago

    Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate

    Logo of Moderna, Inc.
  • PRESS RELEASE

    published on 01/17/2023 at 22:05, 3 years 2 months ago

    Moderna Announces mRNA-1345, an Investigational Respiratory Syncytial Virus (RSV) Vaccine, Has Met Primary Efficacy Endpoints in Phase 3 Trial in Older Adults

    Logo of Moderna, Inc.
  • PRESS RELEASE

    published on 01/09/2023 at 13:00, 3 years 2 months ago

    Moderna Announces Advances Across mRNA Pipeline and Provides Business Update

    Logo of Moderna, Inc.
  • PRESS RELEASE

    published on 01/05/2023 at 22:05, 3 years 2 months ago

    Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics

    Logo of Moderna, Inc.
Previous page
1 ... 33 34
Accesswire
  • Published on 03/19/2026 at 01:05, 5 hours 17 minutes ago

    Prospect Ridge Announces Closing of Flow-Through Share Private Placement

  • Published on 03/18/2026 at 23:45, 6 hours 37 minutes ago

    Orogen Royalties Announces Private Placement Update

  • Published on 03/18/2026 at 21:00, 9 hours 22 minutes ago

    PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie

  • Published on 03/18/2026 at 19:05, 11 hours 17 minutes ago

    Deposit Modeling at Thor Shows that the Proven Thor Epithermal Deposit is Flanked on Both Sides by a Much Larger Deposit

  • Published on 03/18/2026 at 18:10, 12 hours 12 minutes ago

    Silver X Mining Closes C$69M Brokered Private Placement of Secured Convertible Debentures

View all ACCESSWIRE
EQS Group
  • Published on 03/19/2026 at 06:05, 16 minutes ago

    Global terrorism falls to a decade low but Western fatalities surge

  • Published on 03/19/2026 at 03:50, 2 hours 31 minutes ago

    AWE2026 Signals the Future: A Defining Moment for the Age of AI

  • Published on 03/18/2026 at 22:00, 8 hours 22 minutes ago

    aap successfully completes MDR certification: All existing products approved according to MDR – market access in the EU and CE-relevant markets secured in the long term

  • Published on 03/18/2026 at 18:53, 11 hours 28 minutes ago

    EQS-Adhoc: Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025

  • Published on 03/18/2026 at 18:37, 11 hours 45 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

View all EQS
Les Echos
  • Published on 03/18/2026 at 19:41, 10 hours 40 minutes ago

    Covivio - Conditions of availability of the 2025 Universal Registration Document

  • Published on 03/18/2026 at 19:41, 10 hours 40 minutes ago

    Covivio - Modalités de mise à disposition du Document d'Enregistrement Universel 2025

  • Published on 03/18/2026 at 19:36, 10 hours 46 minutes ago

    Covivio Hotels - Modalités de mise à disposition du Document d'Enregistrement Universel 2025

  • Published on 03/18/2026 at 18:00, 12 hours 22 minutes ago

    Communiqué de presse – Résultats annuels 2025

  • Published on 03/18/2026 at 18:00, 12 hours 22 minutes ago

    Deezer achieves profitability in FY25 as strategy delivers tangible results

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy